A1c has limits: it cannot capture other critical outcomes that matter to patients on a daily basis. Low blood sugar (hypoglycemia) can be fatal, and yet, A1c tells us nothing about it. This article unpacks why going beyond A1c is important and shares other ways of measuring diabetes success.
Following the terminated partnership with Sanofi, MannKind has relaunched its ultra-rapid-acting inhaled (needle free) mealtime insulin, Afrezza. Afrezza is an ultra-rapid-acting insulin for people with type 1 and 2 diabetes, peaking in only 16-21 minutes versus about 60-90 minutes for current injected rapid-acting insulins such as Humalog and Novolog .
People with diabetes are, unfortunately, often beset with a host of other health problems, including troubles with their eyesight. And a new study indicates that vision loss is rising worldwide, with diabetes as the main causal factor.
The FDA has cleared InPen, Companion Medical’s reusable Bluetooth-enabled smart insulin pen and paired Apple iOS smartphone app. A launch is expected in 2017, likely including Android, too.
Many people with type 2 diabetes take the drug metformin to control their blood sugar levels. But now, new research suggests that his drug may also benefit type 1 diabetics, by slowing down the progression of heart disease.
For the bionic pancreas to win FDA approval, it will need to prove that the novel aspects of the treatment are safe and effective. Recently, a team of researchers at the Massachusetts General Hospital Diabetes Center in Boston conducted a trial that focused exclusively on the automated delivery of glucagon to see if the treatment […]
The results were, to many, surprising: “Among different fats, the most consistent benefits were seen for increasing polyunsaturated fats, in place of either carbohydrates or saturated fat,” said Imamura. In fact, these results revealed that a diet rich in monounsaturated and polyunsaturated fats can help improve blood sugar control.
A new study confirms what many with diabetes have known all along – that staying healthy comes at a steep price. Researchers with the Health Care Cost Institute found that health care costs for people with diabetes on private insurance plans was about 3.6 times more than health care costs for those without diabetes.
“In large epidemiological studies, the evidence for flossing turns out to be fairly weak,” says Tim Iafolla, a dentist with the National Institute of Dental and Craniofacial Research, which is part of the National Institutes of Health.
If the panel’s recommendations are adopted by the FDA, that would mean that Dexcom G5 users would not need to do a separate fingerstick with a meter to get a blood sugar reading for basal and bolus insulin dosing; they would, however, still need to do daily fingersticks to calibrate the device. European G5 users […]
This June, a 41-year-old man became the first European patient with Type 1 to come off insulin therapy after receiving a transplant of pancreatic islet cells using the BioHub technique. This therapy, engineered by the Diabetes Research Institute (DRI), protects transplanted islet cells from immune system attack.
Just when you thought it was safe to start talking to people with diabetes, here it is: a new collection of statements that have been known to make people with diabetes cringe, twitch, and fume.
Simply reminding yourself that you’re an OK person may increase your readiness to change. In a review published in 2014, Epton and colleagues analyzed existing research and found self-affirmation techniques combined with persuasive health information can help people decide to change — and then actually do it.
Researchers analyzed information from more than 2,600 adolescents ages 12 to 19 who were tested for diabetes at some point from 2005 to 2014, as part of a national health survey conducted by researchers at the Centers for Disease Control and Prevention. Participants underwent three tests of their blood glucose levels, and a person was […]
At the ADA Scientific Sessions in New Orleans, Abbott shared results of the IMPACT study, a randomized six-month trial comparing the FreeStyle Libre “flash glucose monitor” to fingersticks in people with type 1 diabetes
A bloodless way to test blood sugar has long been the stuff of science fiction. But, now, a group of researchers in Wales is moving an innovative idea of drawing blood without puncturing the skin from the conceptual world of Star Trek to perhaps being available at a pharmacy down the street.
At the recent ADA Scientific Sessions, Medtronic presented data from its pivotal trial of the MiniMed 670G/Enlite 3 hybrid closed loop system, designed to provide evidence for regulatory approval.
Research published Wednesday found that states that legalized medical marijuana — which is sometimes recommended for symptoms like chronic pain, anxiety or depression — saw declines in the number of Medicare prescriptions for drugs used to treat those conditions and a dip in spending by Medicare Part D, which covers the cost on prescription medications.
There’s good news on the horizon for those who suffer from diabetes: a new technology that enables the creation of an artificial pancreas could replace your insulin shots and automatically regulate the body’s levels with nothing for you to worry about on your side.
Over a one-year study, glycemic control was improved and body weight and blood pressure were reduced with Invokana® (canagliflozin, Janssen) as add-on therapy to metformin in patients with type 2 diabetes, according to a presentation at AACE.